scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10549-014-2968-9 |
P698 | PubMed publication ID | 24756187 |
P50 | author | Eric Winer | Q16887072 |
Ines Vaz-Luis | Q87608362 | ||
Rachel A Freedman | Q87938499 | ||
Nancy U Lin | Q89531596 | ||
Nancy Keating | Q91842955 | ||
Huichuan Lii | Q125263909 | ||
P2093 | author name string | William T Barry | |
P433 | issue | 2 | |
P304 | page(s) | 491-501 | |
P577 | publication date | 2014-04-23 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy | |
P478 | volume | 145 |
Q39089103 | Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527 |
Q40583931 | Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer |
Q44446068 | Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change |
Q58605565 | Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California |
Q87938502 | Breast cancer-specific survival by age: Worse outcomes for the oldest patients |
Q38670254 | Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer. |
Q31032887 | Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data |
Q37258848 | Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes |
Q90577057 | Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients |
Q47575598 | Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy |
Q94561483 | Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies |
Q41457799 | Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients |
Q28079170 | Specific Aspects of Breast Cancer Therapy of Elderly Women |
Q36754437 | Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice |
Q92365181 | The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence |
Q38594154 | Treatment of Breast Cancer in the Elderly |
Q91045690 | Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016) |
Q28079391 | Twenty years of anti-HER2 therapy-associated cardiotoxicity |
Search more.